PubMed Health⌕ Search

Biomedical subjects

Michael J Harnish

Publications and source records attributed to Michael J Harnish.

2 recordsLinked to original sources

Beta-adrenoceptor-induced inhibition of rat splenocyte proliferation: cytokine gene transcription as the target of action.

Recently, we have demonstrated that behavioral conditioning reduced splenocyte proliferation and IL-2 production in DA rats, and that these behaviorally conditioned immunosuppressive effects were completely abrogated by prior surgical denervation of the spleen. Since the splenic denervation significantly reduced catecholamine concentrations in the spleen, adrenergic mechanisms have been considered to play an important role in conditioned immunosuppression observed in this model. Thus, the current in vitro studies were designed to analyze the influence of adrenergic mechanisms on the proliferation of rat splenocytes, their IL-2 production, and IL-2 mRNA expression. The data demonstrate that beta-adrenoceptor agonist isoproterenol at concentrations of 10(-5) M diminished mitogen (ConA)-induced splenocyte proliferation by 75%, which was associated with a pronounced (50%) decrease in IL-2 production at both the protein and mRNA levels. The beta-adrenoceptor antagonist propranolol completely reversed the isoproterenol-mediated suppressive effects. Stimulation of splenocytes with the mitogen and either the alpha1-adrenoceptor agonist methoxamine or the alpha2-adrenoceptor agonist UK-14,304 did not affect splenocyte proliferation, IL-2 synthesis or IL-2 mRNA expression. These data demonstrate that catecholamines inhibit splenocyte proliferation and IL-2 production via a beta-adrenoceptor-induced regulation of IL-2 mRNA expression, indicating that beta-adrenoceptor mechanisms are responsible for behaviorally conditioned immunosuppression.

Adrenergic alpha-Agonists↗

Autonomic functioning during REM sleep differentiates IBS symptom subgroups.

OBJECTIVE: The aim of this study was to investigate autonomic activity by means of heart rate variability analysis in a sample of irritable bowel syndrome (IBS) patients, allowing stratification into IBS symptom subgroups. METHODS: Thirty-three female IBS patients (mean age 37 yr) and 21 healthy female controls (mean age 38 yr) participated. Patients were stratified into 16 subjects with only lower bowel symptoms (IBS only) and 17 subjects with both lower bowel and dyspeptic symptoms (IBS+D). The protocol included standard polysomnography to assess stages of sleep with concomitant electrocardiographic measurement of beat-to-beat intervals of the cardiac cycle. Fifteen-min segments were selected from presleep waking, stage 2 of non-rapid eye movement (REM), and REM sleep and analyzed by spectral analysis of heart rate variability to calculate the high-frequency band, a measure of vagal tone, and the low-frequency/high-frequency ratio, an indicator of sympathovagal balance. RESULTS: The high-frequency band power during REM sleep was significantly lower, indicating substantial vagal withdrawal in IBS-only patients compared with IBS+D patients and controls. The low-frequency/high-frequency band ratio was significantly higher during REM sleep for IBS-only patients. CONCLUSIONS: IBS-only patients had greater sympathetic dominance, indicated by elevated low-frequency/high-frequency band ratio, during REM sleep because of vagal withdrawal. Autonomic functioning, unique to REM sleep, differentiates IBS symptom subgroups, suggesting that autonomic functioning during REM sleep may be a useful biological marker to identify IBS patient subgroups.

Adult↗